1. Home
  2. |Insights
  3. |DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment

DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment

Firm News | 1 min read | 12.06.21

San Francisco – December 6, 2021: Crowell & Moring represented BayWa Venture GmbH, the investment and collaboration arm of BayWa AG (BYW:Xetra) in its investment in the Israeli start-up YoFix Probiotics’ $3.5 million second financing round.  YoFix Probiotics produces alternatives to milk and dairy products such as yogurt and porridge, using oats, lentils, sunflower seeds, sesame and coconut in place of milk.  YoFix Probiotics is BayWa Venture’s third investment in the field of alternative proteins so far this year.  The transaction was led by senior counsel Mark Kass (Washington) with support from partner Jon O’Connell (San Francisco) and counsel Matt Pelnar (San Francisco).

Insights

Firm News | 5 min read | 08.06.25

Leading Health Care Practices Combine to Provide Comprehensive Counsel to Clients at a Time of Tremendous Change Across the Industry

Chicago – August 06, 2025: Crowell & Moring today announced that a group of 16 highly regarded health care litigation partners is joining the firm, together with their team, and led by accomplished trial attorney Martin J. Bishop. The strategic combination creates one of the largest health care practices in the country and expands the firm’s ability to provide clients across the industry with the full spectrum of litigation, investigations, regulatory, transactional, and recovery capabilities. The team joins from Reed Smith, where Bishop served on the firm’s executive committee....